NCT07586865: Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction
- State
- Not started
- Phase
- Phase 2
- People
- 189 planned
- Started
- 18 May 2026
- Primary completion
- 17 Aug 2027
- Arms
- NL005 10 µg/kg Group, NL005 20 µg/kg Group
- Results
- None posted
- 14 May 2026: Trial registered